Top Markets
Coin of the day
BrainsWay Ltd. BrainsWay Ltd.

BrainsWay Ltd.

BWAY
Rang in aandelen #34049
Established in Jerusalem, Israel, in 2003, BrainsWay Ltd. specializes globally... Established in Jerusalem, Israel, in 2003, BrainsWay Ltd. specializes globally in creating and distributing advanced, non-invasive neurostimulation therapies designed to address a wide array of mental health and neurological conditions. The company's primary innovation is its Deep Transcranial Magnetic Stimulation (dTMS) platform, which offers treatment for disorders including major and anxious depression, obsessive-compulsive disorder, nicotine addiction, bipolar disorder, post-traumatic stress disorder, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post-stroke rehabilitation, and Parkinson's disease. BrainsWay's solutions are primarily adopted by psychiatric practitioners, hospitals, and medical centers across the United States, Europe, Israel, and other international markets.
Aandeelprijs
$15.79
Laatst gesynchroniseerd: 2026-08-14
Marktkapitalisatie
$6.34M
Verandering (1 dag)
-2.64%
Verandering (1 jaar)
134.28%
Land
IL
Handel BrainsWay Ltd. (BWAY)

Categorie

Dividendrendementgeschiedenis voor BrainsWay Ltd. (BWAY)
Het dividendrendement (TTM) van BrainsWay Ltd. (aandelsymbool: BWAY) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van BrainsWay Ltd. (BWAY) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten